FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3006500645> ?p ?o ?g. }

• W3006500645 endingPage "77" @default.
• W3006500645 startingPage "77" @default.
• W3006500645 abstract "Background and Objectives: Obstructive sleep apnoea (OSA) is associated with heightened systemic inflammation and a hypercoagulation state. Soluble urokinase-type plasminogen activator receptor (suPAR) plays a role in fibrinolysis and systemic inflammation. However, suPAR has not been investigated in OSA. Materials and Methods: A total of 53 patients with OSA and 15 control volunteers participated in the study. Medical history was taken and in-hospital sleep studies were performed. Plasma suPAR levels were determined by ELISA. Results: There was no difference in plasma suPAR values between patients with OSA (2.198 ± 0.675 ng/mL) and control subjects (2.088 ± 0.976 ng/mL, p = 0.62). Neither was there any difference when patients with OSA were divided into mild (2.134 ± 0.799 ng/mL), moderate (2.274 ± 0.597 ng/mL) and severe groups (2.128 ± 0.744 ng/mL, p = 0.84). There was no significant correlation between plasma suPAR and indices of OSA severity, blood results or comorbidities, such as hypertension, diabetes, dyslipidaemia or cardiovascular disease. Plasma suPAR levels were higher in women when all subjects were analysed together (2.487 ± 0.683 vs. 1.895 ± 0.692 ng/mL, p < 0.01), and also separately in controls (2.539 ± 0.956 vs. 1.411 ± 0.534 ng/mL, p = 0.02) and patients (2.467 ± 0.568 vs. 1.991 ± 0.686 ng/mL, p < 0.01). Conclusions: Our results suggest that suPAR does not play a significant role in the pathophysiology of OSA. The significant gender difference needs to be considered when conducting studies on circulating suPAR." @default.
• W3006500645 created "2020-02-24" @default.
• W3006500645 creator A5006327846 @default.
• W3006500645 creator A5016408984 @default.
• W3006500645 creator A5021867804 @default.
• W3006500645 creator A5022915762 @default.
• W3006500645 creator A5034290824 @default.
• W3006500645 creator A5059243506 @default.
• W3006500645 creator A5062267690 @default.
• W3006500645 date "2020-02-14" @default.
• W3006500645 modified "2023-10-16" @default.
• W3006500645 title "Circulating Soluble Urokinase-Type Plasminogen Activator Receptor in Obstructive Sleep Apnoea" @default.
• W3006500645 cites W1545241942 @default.
• W3006500645 cites W1569358024 @default.
• W3006500645 cites W1590094710 @default.
• W3006500645 cites W1872224462 @default.
• W3006500645 cites W1884466283 @default.
• W3006500645 cites W1939396410 @default.
• W3006500645 cites W1965141648 @default.
• W3006500645 cites W1975275572 @default.
• W3006500645 cites W1981025834 @default.
• W3006500645 cites W1986947132 @default.
• W3006500645 cites W1997506248 @default.
• W3006500645 cites W1998225326 @default.
• W3006500645 cites W2051611244 @default.
• W3006500645 cites W2052133198 @default.
• W3006500645 cites W2055305484 @default.
• W3006500645 cites W2059215389 @default.
• W3006500645 cites W2067555367 @default.
• W3006500645 cites W2072500831 @default.
• W3006500645 cites W2092315610 @default.
• W3006500645 cites W2095682229 @default.
• W3006500645 cites W2117834225 @default.
• W3006500645 cites W2124107576 @default.
• W3006500645 cites W2127558237 @default.
• W3006500645 cites W2164269274 @default.
• W3006500645 cites W2169162913 @default.
• W3006500645 cites W2286875504 @default.
• W3006500645 cites W2395929742 @default.
• W3006500645 cites W2412055773 @default.
• W3006500645 cites W2549047171 @default.
• W3006500645 cites W2556167549 @default.
• W3006500645 cites W2745078519 @default.
• W3006500645 cites W2791348932 @default.
• W3006500645 cites W2792194195 @default.
• W3006500645 cites W2801781415 @default.
• W3006500645 cites W2898842147 @default.
• W3006500645 cites W2912348760 @default.
• W3006500645 cites W2918792828 @default.
• W3006500645 cites W2945464151 @default.
• W3006500645 cites W4213186691 @default.
• W3006500645 doi "https://doi.org/10.3390/medicina56020077" @default.
• W3006500645 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7074407" @default.
• W3006500645 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32075014" @default.
• W3006500645 hasPublicationYear "2020" @default.
• W3006500645 type Work @default.
• W3006500645 sameAs 3006500645 @default.
• W3006500645 citedByCount "4" @default.
• W3006500645 countsByYear W30065006452020 @default.
• W3006500645 countsByYear W30065006452021 @default.
• W3006500645 crossrefType "journal-article" @default.
• W3006500645 hasAuthorship W3006500645A5006327846 @default.
• W3006500645 hasAuthorship W3006500645A5016408984 @default.
• W3006500645 hasAuthorship W3006500645A5021867804 @default.
• W3006500645 hasAuthorship W3006500645A5022915762 @default.
• W3006500645 hasAuthorship W3006500645A5034290824 @default.
• W3006500645 hasAuthorship W3006500645A5059243506 @default.
• W3006500645 hasAuthorship W3006500645A5062267690 @default.
• W3006500645 hasBestOaLocation W30065006451 @default.
• W3006500645 hasConcept C10162356 @default.
• W3006500645 hasConcept C126322002 @default.
• W3006500645 hasConcept C134018914 @default.
• W3006500645 hasConcept C170493617 @default.
• W3006500645 hasConcept C2776252253 @default.
• W3006500645 hasConcept C2776825266 @default.
• W3006500645 hasConcept C2776892390 @default.
• W3006500645 hasConcept C2776914184 @default.
• W3006500645 hasConcept C2776929539 @default.
• W3006500645 hasConcept C2779679481 @default.
• W3006500645 hasConcept C3018023364 @default.
• W3006500645 hasConcept C56219504 @default.
• W3006500645 hasConcept C71924100 @default.
• W3006500645 hasConcept C90924648 @default.
• W3006500645 hasConceptScore W3006500645C10162356 @default.
• W3006500645 hasConceptScore W3006500645C126322002 @default.
• W3006500645 hasConceptScore W3006500645C134018914 @default.
• W3006500645 hasConceptScore W3006500645C170493617 @default.
• W3006500645 hasConceptScore W3006500645C2776252253 @default.
• W3006500645 hasConceptScore W3006500645C2776825266 @default.
• W3006500645 hasConceptScore W3006500645C2776892390 @default.
• W3006500645 hasConceptScore W3006500645C2776914184 @default.
• W3006500645 hasConceptScore W3006500645C2776929539 @default.
• W3006500645 hasConceptScore W3006500645C2779679481 @default.
• W3006500645 hasConceptScore W3006500645C3018023364 @default.
• W3006500645 hasConceptScore W3006500645C56219504 @default.
• W3006500645 hasConceptScore W3006500645C71924100 @default.
• W3006500645 hasConceptScore W3006500645C90924648 @default.
• W3006500645 hasFunder F4320321102 @default.

• next